Join Dr. Wendy S. Myers on November 3, 2026, at 7:00 p.m. (EST) for this live presentation, where she will share her best practices for working with clients to improve treatment adherence in cats with diabetes. Veterinarians and their teams play a pivotal role in helping diabetic cats thrive. This webcast will show you how to do it with clarity, confidence, and compassion. Learn communication techniques that strengthen client trust, boost compliance, and make once-daily dosing easier for...

Join Dr. Susan Little on October 20, 2026, at 7 p.m. (EDT) for this presentation, as she reviews the new SGLT2 inhibitor class of drugs for the treatment of diabetes in cats. In this presentation, Dr. Little will review the new SGLT2 inhibitor class of drugs for the treatment of diabetes in cats, including the mechanism of action, clinical efficacy, and potential adverse events. How to identify the best candidates for treatment will be discussed and practical recommendations for monitoring...

In this webcast, Dr. Colpitts provides an in-depth review of the key risk factors associated with Feline Arterial Thromboembolism (ATE). She explains how blood clots form and why they lead to the clinical symptoms seen in affected cats. The presentation also explores current medical options available for reducing the risk of ATE, including treatment strategies tailored to individual patient needs. This informative session is designed to help veterinary professionals better understand,...

Join Professor Paulo Steagall, world-renowned expert in veterinary anesthesia and pain management, for a webcast dedicated to optimising analgesia in cats. In this session, Professor Steagall will explore the importance of individualised, multimodal analgesic strategies and how they can significantly improve outcomes in feline osteoarthritis. You will learn to: Identify key risk factors for feline osteoarthritis Understand the critical role of caregiver engagement in long-term pain...

Explore how you can improve diabetes management in feline patients through a Spectrum of Care approach. In this webcast, Dr. Susan Little will focus on the recent advancements in treating diabetes mellitus in cats. While we can’t say goodbye to insulin yet, new oral medications have revolutionized care for diabetic cats. Dr. Little will review a range of treatment options, and she will discuss the best candidate patients for each one in the context of providing a Spectrum of Care. She will...

In this webinar, Dr von Pückler discusses the role of diagnostic imaging in canine osteoarthritis: Discover the benefits of including a radiographic evaluation in osteoarthritis diagnosis rather than starting treatment based on clinical symptomsLearn about the differences in radiographic appearance of early versus advanced osteoarthritisDiscover the radiographic signs to look for to diagnose predisposing arthropathiesUnderstand potential limitations of radiography and how to overcome...

While insulin has been a mainstay in the treatment of feline diabetes for decades, new treatments and creative monitoring options have increased our ability to provide individualized care. In this presentation, we will explore an expanding range of therapeutic options—from nutrition to insulin to the newer SGLT2 inhibitors. Throughout the session, we will examine how these options support the concept of Spectrum of Care.

Before 2009, Echinococcus multilocularis had never been diagnosed in a dog in Canada. Since then, many cases have been identified in dogs, humans, and wildlife across the country. In this webcast, Dr. Andrew Peregrine will highlight key developments from the past four years in Canada and the USA, including the latest data on the geographic distribution of alveolar echinococcosis (AE) and intestinal infections in dogs, AE cases in humans, and the prevalence of intestinal infections in wild...

During this webcast, Dr. Gordon will address common questions regarding best practices for primary care veterinarians managing dogs with heart disease. The emphasis will be on the diagnosis, staging, and management of myxomatous mitral valve disease, with particular attention to strategies for navigating budgetary restrictions.